The Ministry of Health announced the guidelines for vaccination against coronavirus to minors who suffer from comorbidities that put them especially at risk of suffering from the disease in a serious way.
Through a list, he made known what are the conditions that he contemplates for immunization to adolescents from 12 to 17 years old, who will receive the biological from Pfizer, the only one that has been approved for use in minors.
For this health procedure, nine priority groups are considered, ranging from chronic heart conditions to teenage pregnancy, the groups are as follows:
Chronic heart conditions
In the first risk group to be vaccinated are those with chronic conditions, congenital or acquired heart disease with data of heart failure, primary or secondary arterial hypertension under medical treatment with anti-hypertensive drugs.
Chronic lung disease
In a second includes those with chronic lung diseaseAmong these, ciliary dyskinesias, that is, hereditary pathology characterized by a structural defect of the hair cells present in the respiratory and gonadal tissues.
Suffer severe poorly controlled asthma, use of high-dose inhaled steroids along with a second controller medication in addition to at least one of the following: use of 3 or more cycles of systemic steroid in the past year for asthma exacerbations, or one or more hospitalizations for asthma in the previous year.
The guideline highlights that “patients with adequate inhaler-based control are not eligible in this group.”
Chronic disorders of the kidney, liver or digestive system
In the third group are those of chronic conditions of the kidney, liver or digestive system and, among the specific conditions, it is established: congenital malformations of the kidney, liver or digestive system that pose a risk to life.
In addition, severe gastroesophageal reflux which can predispose to respiratory infections, patients with gastrostomy, cirrhosis, biliary atresia, chronic hepatitis, chronic renal failure grade 3 or higher including patients with replacement therapy (hemodialysis or peritoneal dialysis).
Chronic neurological disease
Fourth are those with chronic neurological diseases and that encompasses neurodisability or neuromuscular disease including cerebral palsy, moderate or severe autism, hard-to-control epilepsy with neurological impairment, and muscular dystrophy.
Congenital disorders that can affect the nervous system; Hereditary and degenerative disease of the nervous system or muscles or other conditions associated with hypoventilation.
Multiple or severe or profound learning disabilities (PMLD); myasthenia and related diseases. Also multiple sclerosis and Down syndrome.
The fifth group are minors with endocrine diseases, diabetes mellitus In any of its forms and degree of control, Addison’s Syndrome, Hypopituitary Syndrome and severe obesity.
Moderate to severe immunosuppression
In sixth place is the moderate to severe immunosuppression by active treatment for solid tumors or hematologic malignancies (leukemia, lymphoma, and myeloma), or within 3 years of healing.
In addition, solid organ or stem cell transplant recipients are found within 2 years after transplantation or receiving immunosuppressive treatment. People on the transplant waiting list.
Moderate or severe primary immunodeficiency, for example, DiGeorge syndrome, WiskottAldrich syndrome, Common Variable Immunodeficiency or secondary to disease or treatment. Active treatment with immunosuppressants producing significant immunosuppression by high-dose corticosteroids in girls, children and adolescents over 110 kilos and using prednisone or its equivalent per day when administered for 2 weeks.
In this category are minors who use alkylating agents, antimetabolites, immunosuppressive drugs related to transplantation; cancer chemotherapeutics, tumor necrosis factor blockers and other drugs that are significantly immunosuppressive or have received them in the previous 6 months, immunosuppressive chemotherapy or radiation therapy.
Autoimmune diseases that can requiring long-term immunosuppressive treatments, systemic lupus erythematosus and rheumatoid arthritis, among others. HIV / AIDS and Tuberculosis infection.
Asplenia or spleen dysfunction and hematological diseases
In the seventh they are located minors with asplenia or spleen dysfunction and hematological diseases associated with hereditary spherocytosis, homozygous sickle cell disease, thalassemia major, and hemophilia.
Serious genetic abnormalities affecting multiple systems
In the eighth group are the severe genetic abnormalities that affect multiple systems, among these, mitochondrial diseases, chromosomal and lysosomal abnormalities and innate errors of metabolism.
And the ninth covers teenage pregnancy from 9 weeks of pregnancy. Girls aged 10 and 11 are excluded.
With information from Blanca Valadez